ACTIVE

STEVENS PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

39,3 k €

+65.5% YoY

Gross margin

165,1 k €

+23.9% YoY

Equity

324,7 k €

+13.8% YoY

Workforce

1,3 ETP

0.0% YoY

What does STEVENS PHARMA do?

STEVENS PHARMA is a Public limited company incorporated in 1990. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wezembeek-Oppem. It employs on average 1,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0442.284.960

Incorporation

17/10/1990

Legal form

Public limited company

Registered office

Chaussée de Malines 130
1970 Wezembeek-Oppem · FlandreSee on map

Contributed capital

61 973,38 €

Latest accounts

31/12/2025

Average workforce

1,3 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	165,1 k €	+23.9%	133,3 k €	+3.8%	128,5 k €	+33.9%	96 k €	+6.6%	90 k €	-23.4%	117,4 k €	-3.0%	121 k €	-4.9%	127,2 k €	+18.7%	107,2 k €	-31.9%	157,5 k €	+31.7%	119,5 k €	+5.2%	113,6 k €	+19.7%	94,9 k €	-4.8%	99,7 k €	+73.4%	57,5 k €	-32.7%	85,5 k €	-23.8%	112,2 k €	+21.9%	92 k €	+14.1%	80,6 k €	-29.0%	113,6 k €
EBITDA	72,9 k €	+68.4%	43,3 k €	+14.9%	37,7 k €	+244%	10,9 k €	+11.4%	9,8 k €	-71.9%	35 k €	-14.6%	41 k €	-12.0%	46,5 k €	+44.2%	32,3 k €	-62.7%	86,5 k €	+41.6%	61,1 k €	-23.1%	79,5 k €	+51.3%	52,5 k €	-1.6%	53,4 k €	+2684%	-2,1 k €	-112%	17,8 k €	-48.7%	34,8 k €	+0.9%	34,5 k €	+12.4%	30,7 k €	-27.9%	42,5 k €
Operating result	55,3 k €	+64.9%	33,5 k €	+8.7%	30,9 k €	+348%	6,9 k €	-7.8%	7,5 k €	-77.8%	33,6 k €	-14.0%	39,1 k €	-13.0%	44,9 k €	+64.4%	27,3 k €	-66.0%	80,4 k €	+48.0%	54,3 k €	-26.7%	74,1 k €	+62.3%	45,6 k €	+1.1%	45,1 k €	+505%	-11,1 k €	-328%	4,9 k €	-68.7%	15,6 k €	-22.9%	20,2 k €	+55.3%	13 k €	-46.8%	24,5 k €
Net result	39,3 k €	+65.5%	23,7 k €	+5.9%	22,4 k €	+263%	6,2 k €	+2.9%	6 k €	-75.5%	24,5 k €	-16.6%	29,4 k €	-10.7%	32,9 k €	+78.0%	18,5 k €	-64.5%	52,1 k €	+46.0%	35,7 k €	-28.1%	49,6 k €	+46.3%	33,9 k €	-26.6%	46,2 k €	+830%	-6,3 k €	-150%	-2,5 k €	-114%	17,7 k €	-36.2%	27,8 k €	+92.5%	14,5 k €	+2225%	621,7 €
Balance sheet
Equity	324,7 k €	+13.8%	285,4 k €	+9.1%	261,7 k €	+9.4%	239,3 k €	-5.2%	252,4 k €	-27.5%	348,1 k €	+7.6%	323,6 k €	+10.0%	294,2 k €	+12.6%	261,4 k €	+7.6%	242,9 k €	+27.3%	190,8 k €	+23.0%	155,1 k €	+47.0%	105,5 k €	-69.1%	341,6 k €	+15.7%	295,3 k €	-2.1%	301,7 k €	-0.8%	304,2 k €	+6.2%	286,5 k €	+5.5%	271,6 k €	+5.6%	257,2 k €
Total assets	406,5 k €	-9.8%	450,6 k €	+15.1%	391,4 k €	-0.8%	394,4 k €	-3.1%	407 k €	-0.8%	410,1 k €	+3.2%	397,5 k €	+4.6%	380,1 k €	+10.1%	345,3 k €	-2.0%	352,3 k €	+6.3%	331,5 k €	+3.0%	321,7 k €	-24.7%	427,3 k €	-1.7%	434,7 k €	+9.9%	395,6 k €	-0.2%	396,3 k €	+0.6%	394,1 k €	-1.6%	400,6 k €	+9.4%	366,2 k €	-3.9%	381,2 k €
Cash	113,3 k €	-24.7%	150,5 k €	+53.4%	98,1 k €	-22.2%	126,1 k €	-32.7%	187,3 k €	-1.2%	189,5 k €	+11.1%	170,6 k €	+13.2%	150,8 k €	+42.1%	106,1 k €	-0.3%	106,5 k €	+83.5%	58 k €	+8.0%	53,7 k €	+5.7%	50,8 k €	+6.2%	47,8 k €	+40.1%	34,1 k €	+47.1%	23,2 k €	-31.6%	33,9 k €	-8.7%	37,1 k €	-2.2%	38 k €	+38.2%	27,5 k €
Debts	81,8 k €	-50.5%	165,2 k €	+27.3%	129,7 k €	-15.8%	154 k €	+0.3%	153,5 k €	+152%	60,9 k €	-16.3%	72,7 k €	-14.2%	84,8 k €	+2.4%	82,8 k €	-23.3%	107,9 k €	-22.5%	139,3 k €	-15.7%	165,3 k €	-47.9%	317,6 k €	+265%	87,1 k €	-10.6%	97,5 k €	+6.0%	91,9 k €	+5.5%	87,1 k €	-14.1%	101,4 k €	+19.8%	84,7 k €	-21.9%	108,4 k €
Other
Workforce	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	+117%	0,6 ETP	-57.1%	1,4 ETP	0.0%	1,4 ETP	-26.3%	1,9 ETP	-13.6%	2,2 ETP	-12.0%	2,5 ETP	+8.7%	2,3 ETP	+53.3%	1,5 ETP	-28.6%	2,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 26 ended

Active mandates

Ilse Stevens

Director

Active

Ended mandates

Ilse Elisabeth Stevens

Managing director · since 07 juin 2019 · until 06 juin 2025

Ended

Marie-Jeanne Janssens

Director · since 07 juin 2019 · until 06 juin 2025

Ended

Ilse Stevens

Managing director · since 01 janvier 2018

Ended

Johan VANLERBERGHE

Director · since 01 janvier 2018 · until 07 juin 2019

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/07/2026	07/07/2025	29/08/2024	31/08/2023	31/08/2022	18/08/2021
General meeting	26/06/2026	06/06/2025	30/06/2024	23/06/2023	30/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	13/07/2026	Dutch	PDF
Abridged model	31/12/2024	06/06/2025	07/07/2025	Dutch	PDF
Abridged model	31/12/2023	30/06/2024	29/08/2024	Dutch	PDF
Abridged model	31/12/2022	23/06/2023	31/08/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	31/08/2022	Dutch	PDF
Abridged model	31/12/2020	25/06/2021	18/08/2021	Dutch	PDF
Abridged model	31/12/2019	05/06/2020	16/12/2020	Dutch	PDF
Abridged model	31/12/2018	07/06/2019	04/07/2019	Dutch	PDF
Abridged model	31/12/2017	01/06/2018	29/06/2018	Dutch	PDF
Abridged model	31/12/2016	23/06/2017	24/07/2017	Dutch	PDF
Abridged model	31/12/2015	03/06/2016	28/06/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	31/07/2015	Dutch	PDF
Abridged model	31/12/2013	06/06/2014	07/07/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	29/07/2013	Dutch	PDF
Abridged model	31/12/2011	22/06/2012	18/07/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	29/07/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	08/07/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	23/07/2009	Dutch	PDF
Abridged model	31/12/2007	27/06/2008	15/07/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	26/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 26 ended

Active mandates

Ilse Stevens

Director

Active

Ended mandates

Ilse Elisabeth Stevens

Managing director · since 07 juin 2019 · until 06 juin 2025

Ended

Marie-Jeanne Janssens

Director · since 07 juin 2019 · until 06 juin 2025

Ended

Ilse Stevens

Managing director · since 01 janvier 2018

Ended

Johan VANLERBERGHE

Director · since 01 janvier 2018 · until 07 juin 2019

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates07/06/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/09/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/02/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/09/2009
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares07/03/2005
BENAMING - KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates31/12/2003
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202539,3 k €↑
2024
Annual accounts 202423,7 k €↑
2023
Annual accounts 202322,4 k €↑
2022
Annual accounts 20226,2 k €↑
2021
Annual accounts 20216 k €↓
2020
Annual accounts 202024,5 k €↓
2019
Annual accounts 201929,4 k €↓
2018
Annual accounts 201832,9 k €↑
2017
Annual accounts 201718,5 k €↓
2016
Annual accounts 201652,1 k €↑
2015
Annual accounts 201535,7 k €↓
2014
Annual accounts 201449,6 k €↑
2013
Annual accounts 201333,9 k €↓
2012
Annual accounts 201246,2 k €↑
2011
Annual accounts 2011-6,3 k €↓
2010
Annual accounts 2010-2,5 k €↓
2009
Annual accounts 200917,7 k €↓
2008
Annual accounts 200827,8 k €↑
2007
Annual accounts 200714,5 k €↑
2006
Annual accounts 2006621,7 €
17/10/1990
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

STEVENS PHARMA

Overview

What does STEVENS PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline